Verona hires ex-GSK researchers for late-phase push in COPD

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 25, 2019 at 9:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,741
    Likes Received:
    3
    via Verona Pharma has named long-time GlaxoSmithKline employee Nina Church as executive director of global clinical development. The hire is part of efforts to prepare for phase 3 development of ensifentrine in chronic obstructive pulmonary disease.

    article source